Live Watch: A Yahoo Finance special report on Apple's earnings Munich - Delayed Quote • EUR TAURON Polska Energia SA (1T5.MU) Follow Add holdings 1.4355 +0.0455 +(3.27%) At close: April 30 at 9:42:21 AM GMT+2 Related News Apple: Why this analyst isn't 'too concerned' about China tariffs Apple (AAPL) may avoid the worst of upcoming tariffs on China. Antoine Chkaiban, New Street Research technology infrastructure analyst, explains why Apple’s diversification strategy and planned US investments lessen the risk of tariff impacts. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. Reddit beats estimates with strong Q1 and strong outlook Reddit (RDDT) stock is jumping after the company posted first quarter revenue of $392.4 million, higher than the $369.3 million expected, and EBITDA of $115 million, also topping estimates. Rohit Kulkarni, ROTH MKM managing director and senior research analyst, joins Market Domination Overtime to break down the better-than-expected results. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. Amazon's outlook misses. What costs are dragging down guidance? Amazon (AMZN) shares are under pressure in extended-hours trading after the company issued operating income guidance of $13 billion to $17.5 billion, a wide range with the high end below Wall Street's estimates. ROTH MKM managing director and senior research analyst Rohit Kulkarni joins Market Domination Overtime with host Julie Hyman and Yahoo Finance Markets Reporter Josh Schafer to share his instant reaction to Amazon's earnings print. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. Amazon Q1 earnings beat, but weak outlook weighs on stock Amazon (AMZN) stock falls after the company reported first quarter results as the e-commerce giant's weak outlook overshadowed its earnings beat on the top and bottom lines. First quarter net sales were $155.7 billion, slightly ahead of estimates of $155.16 billion, as earnings per share (EPS) came in at $1.59, beating the $1.36 expected. The company issued guidance, saying it expects its second quarter operating income to be between $13 billion and $17.5 billion, with the high end below analyst estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade' Eli Lilly's CEO waved off the Novo Nordisk-CVS GLP-1 formulary deal as he focuses on the future of the company's obesity pipeline. Judge says CEO Tim Cook 'chose poorly' as Apple ignored App Store order A US judge ordered Apple to immediately decrease its App Store fees and asked for criminal prosecutors to review the company's alleged 'cover-up,' jeopardizing billions in revenue for the tech giant. Why the Eli Lilly sell-off may be an 'overreaction' Eli Lilly (LLY) stock is sinking as investors react to concerns around GLP-1 drugs and industry dynamics. Red Brook Advisors managing partner Syed Husain joins Catalysts to discuss the market moves and explain why markets may be overreacting. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. Amazon: What historical trends say about post-earnings trading Amazon (AMZN) reports earnings after the bell on Thursday, and investors are bracing for another potential swing in the stock. Yahoo Finance Markets and Data Editor Jared Blikre breaks down 16 years of post-earnings data. Catch more Stocks in Translation here, with new episodes every Tuesday and Thursday. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. Eli Lilly's Q1 win outweighed by Novo's CVS deal Eli Lilly (LLY) shares slid at the open despite topping first quarter estimates, with investors reacting to the company lowering its full-year profit outlook. Investors are also reacting to a new deal between rival Novo Nordisk (NVO) and CVS (CVS) that could sideline Lilly's weight-loss drug Zepbound. Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to break down what's weighing on Eli Lilly's stock. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Editor's note: The headline was updated to better reflect what is moving the stock. Big Tech earnings, Amazon & Apple, Tesla denies search: 3 Things Meta Platforms (META) and Microsoft (MSFT) released their latest quarterly earnings after the market close on Wednesday, both topping Wall Street expectations. Read up on Yahoo Finance tech editor Dan Howley's coverage of both. Amazon (AMZN) and Apple (AAPL) are next on deck from the Magnificent Seven to report earnings results after the closing bell today. Tesla (TSLA) chair Robyn Denholm has denied reports that the electric vehicle manufacturer has initiated a search for a new CEO to replace Elon Musk. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Epic Games just scored a major win against Apple Epic Games has notched a win in an ongoing legal dispute with Apple, as a result of which Fortnite could return to the U.S. iOS App Store as early as next week. Judge Yvonne Gonzalez Rogers said in a ruling on Wednesday that Apple was in "willful violation" of a 2021 injunction that prohibited the company from imposing anticompetitive pricing. Apple won many of the arguments in the trial with Epic Games. One notable exception was a ruling prohibiting the iPhone maker from collecting fees on purc Performance Overview Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) Return 1T5.MU MSCI WORLD (^990100-USD-STRD) YTD +65.72% -1.48% 1-Year +114.77% +9.46% 3-Year +105.66% +31.05%